Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 25, 2019 Off

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

By BusinessWire

CAMPBELL, Calif.–(BUSINESS WIRE)–Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40…

March 25, 2019 Off

Ocular Therapeutix™ Reports Election of Leslie Williams to Board of Directors

By BusinessWire

BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank"gt;#OCUTXlt;/agt;–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development,…

March 25, 2019 Off

European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint

By BusinessWire

— Company Intends to Submit European MAA in Mid-2019 — — Webcast and Conference Call Today at 8:30 a.m. EDT…

March 25, 2019 Off

NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK’s Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy

By BusinessWire

Completion of Phase 1 First-in-Human Trials of Cryopreserved, Off-The-Shelf haNK Cells Leads the Way to Pivotal Phase 2 Trials in Relapsed Merkel Cell Carcinoma Funding…

March 25, 2019 Off

F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting

By BusinessWire

Three poster presentations highlighting the synergistic benefits of the tetravalent bispecific (mAb2™) format compared to monospecific agents either alone or…

March 25, 2019 Off

H3 Biomedicine Announces Multiple Presentations at Upcoming AACR Annual Meeting

By BusinessWire

–Presentations highlight company’s expertise seamlessly integrating human biology, data science and modern chemistry to advance a pipeline of investigational breakthrough…

March 25, 2019 Off

Bone Biologics Receives Human Research Ethics Committee (HREC) Approval for the First Center of a Multicenter Pilot Clinical Trial to Evaluate NB1 (NELL-1/DBX®) in Australia

By BusinessWire

BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corp. (OTCQB:BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, today has…

March 25, 2019 Off

ZYUS To Acquire Clinical Software Platform from Ehave

By BusinessWire

Assets to further enhance ZYUS cannabinoid clinical trial program SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) has…

March 25, 2019 Off

ZYUS To Acquire Clinical Software Platform from Ehave

By BusinessWire

Assets to further enhance ZYUS cannabinoid clinical trial program SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) has…

March 25, 2019 Off

AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update

By BusinessWire

Recruitment completed in investigator-sponsored Phase 1 Fabry study Phase 1 and Phase 2 clinical data updates for AVR-RD-01 in Fabry…

Posts pagination

Previous 1 … 3,336 3,337 3,338 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine